Interaction of hIAPP with Model Raft Membranes and Pancreatic β‐Cells: Cytotoxicity of hIAPP Oligomers

Type II diabetes mellitus (T2DM) is associated with β‐cell failure, which correlates with the formation of pancreatic islet amyloid deposits. The human islet amyloid polypeptide (hIAPP) is the major component of islet amyloid and undergoes structural changes followed by self‐association and pathological tissue deposition during aggregation in T2DM. There is clear evidence that the aggregation process is accelerated in the presence of particular lipid membranes. Whereas hIAPP aggregation has been extensively studied in homogeneous model membrane systems, especially negatively charged lipid bilayers, information on the interaction of hIAPP with heterogeneous model raft membranes has been missing until now. In the present study, we focus on the principles of aggregation and amyloid formation of hIAPP in the presence of model raft membranes. Time‐lapse tapping mode AFM and confocal fluorescence microscopy experiments followed membrane permeabilization and localization of hIAPP in the raft membrane. Together with the ThT and WST‐1 assay, the data revealed elevated cytotoxicity of hIAPP oligomers on INS‐1E cells.

[1]  R. Kayed,et al.  Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.

[2]  D. Dickson,et al.  Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.

[3]  C. Czeslik,et al.  Interaction of IAPP and insulin with model interfaces studied using neutron reflectometry. , 2009, Biophysical journal.

[4]  C. Haass,et al.  Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.

[5]  E. Gratton,et al.  Partitioning of dual-lipidated peptides into membrane microdomains: lipid sorting vs peptide aggregation. , 2004, Journal of the American Chemical Society.

[6]  R. Raffai,et al.  Cholesterol Published, JLR Papers in Press, January 23, 2003. DOI 10.1194/jlr.R300007-JLR200 , 2003, Journal of Lipid Research.

[7]  S. Ji,et al.  Cholesterol Is an Important Factor Affecting the Membrane Insertion of β-Amyloid Peptide (Aβ1–40), Which May Potentially Inhibit the Fibril Formation* , 2002, The Journal of Biological Chemistry.

[8]  P. Lansbury,et al.  Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. , 2002, Biochemistry.

[9]  R. Seidel,et al.  Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes. , 2009, Journal of molecular biology.

[10]  J. Brender,et al.  Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. , 2009, Journal of the American Chemical Society.

[11]  J. McLaurin,et al.  Cholesterol, a Modulator of Membrane-associated Aβ-fibrillogenesis , 2003, Annals of the New York Academy of Sciences.

[12]  U Aebi,et al.  Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.

[13]  Ralf Langen,et al.  Identifying Structural Features of Fibrillar Islet Amyloid Polypeptide Using Site-directed Spin Labeling* , 2004, Journal of Biological Chemistry.

[14]  R. Winter,et al.  Effect of pressure on islet amyloid polypeptide aggregation: revealing the polymorphic nature of the fibrillation process. , 2008, Biochemistry.

[15]  Christian Leisner,et al.  Raft lipids as common components of human extracellular amyloid fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Kahn,et al.  Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. , 1999, Diabetes.

[17]  Z. Salamon,et al.  Effects of sphingomyelin, cholesterol and zinc ions on the binding, insertion and aggregation of the amyloid Aβ1−40 peptide in solid‐supported lipid bilayers , 2006, The FEBS journal.

[18]  Roland Winter,et al.  Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol , 2009, Chembiochem : a European journal of chemical biology.

[19]  C. Verchere,et al.  Islet amyloid polypeptide and type 2 diabetes , 2003, Experimental Gerontology.

[20]  E. Gazit,et al.  The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. , 2003, Biochemistry.

[21]  E. Gratton,et al.  Visualizing association of N-ras in lipid microdomains: influence of domain structure and interfacial adsorption. , 2006, Journal of the American Chemical Society.

[22]  B. Kurganov,et al.  Aggregation of liposomes induced by the toxic peptides Alzheimer’s Aβs, human amylin and prion (106–126): facilitation by membrane-bound GM1 ganglioside , 2004, Peptides.

[23]  L. Serpell,et al.  Structural characterisation of islet amyloid polypeptide fibrils. , 2004, Journal of molecular biology.

[24]  A. Meister,et al.  Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. , 2007, Biophysical journal.

[25]  B. Wolozin A fluid connection: Cholesterol and Aβ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Kahn,et al.  The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes , 2001 .

[27]  V. Höllt The mu opioid receptor: Molecular and functional aspects , 2004 .

[28]  Roland Winter,et al.  Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study. , 2009, Journal of the American Chemical Society.

[29]  H. Makino,et al.  Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. , 1989, Biochemical and biophysical research communications.

[30]  U. Aebi,et al.  Watching amyloid fibrils grow by time-lapse atomic force microscopy. , 1999, Journal of molecular biology.

[31]  S. Jayasinghe,et al.  Structure of α-Helical Membrane-bound Human Islet Amyloid Polypeptide and Its Implications for Membrane-mediated Misfolding* , 2008, Journal of Biological Chemistry.

[32]  H. Reber,et al.  Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. , 2010, The American journal of pathology.

[33]  J. Brender,et al.  Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. , 2008, Journal of the American Chemical Society.

[34]  J. McLaurin,et al.  Cholesterol, a Modulator of Membrane‐Associated Aβ‐Fibrillogenesis , 2002, Pharmacopsychiatry.

[35]  N. Opitz,et al.  Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol , 2009, FEBS letters.

[36]  Maarten F. M. Engel,et al.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.

[37]  M. Angelova,et al.  Lipid swelling and liposome formation mediated by electric fields , 1988 .

[38]  A. Miranker,et al.  Phospholipid catalysis of diabetic amyloid assembly. , 2004, Journal of molecular biology.

[39]  S. Jayasinghe,et al.  Lipid membranes modulate the structure of islet amyloid polypeptide. , 2005, Biochemistry.

[40]  A. Fink,et al.  Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins. , 2007, Biochimica et biophysica acta.

[41]  B. de Kruijff,et al.  Visualizing detergent resistant domains in model membranes with atomic force microscopy , 2001, FEBS letters.

[42]  A. Miranker,et al.  Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. , 2006, Biochemistry.

[43]  L. Johnston,et al.  Preferential accumulation of Abeta(1-42) on gel phase domains of lipid bilayers: an AFM and fluorescence study. , 2007, Biochimica et biophysica acta.

[44]  C. Betsholtz,et al.  Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[45]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[46]  H. Waldmann,et al.  The lipid modifications of Ras that sense membrane environments and induce local enrichment. , 2009, Angewandte Chemie.

[47]  B. Jena,et al.  Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus. , 2008, Methods in cell biology.

[48]  D. Milardi,et al.  Calcium-activated membrane interaction of the islet amyloid polypeptide: implications in the pathogenesis of type II diabetes mellitus. , 2008, Archives of biochemistry and biophysics.

[49]  Maarten F. M. Engel Membrane permeabilization by Islet Amyloid Polypeptide. , 2009, Chemistry and physics of lipids.

[50]  B. Göke,et al.  Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas. , 1990, Biochemical and biophysical research communications.

[51]  S. Theander,et al.  Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. , 2004, Endocrinology.

[52]  H. Waldmann,et al.  Influence of the lipidation motif on the partitioning and association of N-Ras in model membrane subdomains. , 2009, Journal of the American Chemical Society.

[53]  U. Aebi,et al.  Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation* , 2004, Journal of Biological Chemistry.

[54]  D. W. Hayden,et al.  Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Hai Lin,et al.  Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. Kagan,et al.  Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*) , 1996, The Journal of Biological Chemistry.

[57]  Maarten F. M. Engel,et al.  Islet amyloid polypeptide inserts into phospholipid monolayers as monomer. , 2006, Journal of molecular biology.

[58]  A. Herrmann,et al.  Die Lipidmodifikationen von Ras passen sich an die Membranumgebung an und beeinflussen die lokale Konzentration , 2009 .

[59]  U. Aebi,et al.  Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. , 2004, Journal of molecular biology.

[60]  J. Bernhagen,et al.  Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.

[61]  O. Petersen,et al.  Calcium oscillations [12] , 1989 .

[62]  D. Harrison,et al.  The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. , 1999, Diabetes.